Downstream Processing
-
Upstream To Downstream: A Comprehensive Approach To AAV Production
12/7/2023
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
-
An Innovative Approach To High Aggregate Challenges
7/14/2025
In this webinar, hear from a technical specialist on addressing the challenges with antibody aggregates and process related impurity removal using a new high performance chromatography resins
-
AAV Purification: Solving Downstream Challenges
6/9/2025
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
-
Process Intensification Development Challenges At AZ and AbbVie
8/27/2024
In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists respond to audience questions about the challenges they’ve encountered while developing process intensification strategies.
-
BPI Interviews Purification And Pharma Analytics Leader
6/9/2025
Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.
-
DoE Methodology For Downstream Purification Of pDNA Of IEX Resins
6/16/2025
Learn a systematic approach using Design of Experiment to optimize plasmid DNA purification. See how anion exchange resins are evaluated to enhance dynamic binding capacity and process efficiency.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.
-
Maximize Your Drug Product Recovery With A Complete Fill Finish Solution
5/29/2025
Discover how to maximize drug product recovery with an end-to-end fill-finish solution. Get excellent integrity assurance and exceptional lead times for your critical processes.
-
Speed Up Process Development With HTS Tools For Affinity Chromatography
7/16/2024
High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.
-
Simplify Your Process Of Choosing An Optimal Resin
5/19/2025
Discover how to address evolving biotherapeutic purification challenges with a diverse resin portfolio and an intuitive Resin Selection Tool designed to streamline workflows and enhance production efficiency.